Position in PFE
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$10,150,667
+$1,396,400 QoQ
Shares Held
361,491
+2.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CAISSE DES DEPOTS ET CONSIGNATIONS holds $1,030,891,634 across 8 Drug Manufacturers - General names. PFE ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
4,882,468 | $962,920,338 | |
| 2 | JNJ |
Johnson & Johnson
|
57,843 | $14,139,142 | |
| 3 | ABBV |
AbbVie Inc.
|
60,892 | $13,243,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
91,415 | $10,996,310 | |
| 5 | LLY |
ELI LILLY & Co
|
11,381 | $10,467,902 | |
| 6 | PFE |
Pfizer Inc
This page
|
361,491 | $10,150,667 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
60,140 | $8,381,711 | |
| 8 | AMGN |
Amgen Inc
|
1,683 | $592,163 |
All Filings in PFE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,150,667 | 361,491 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $8,754,267 | 351,577 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8,958,181 | 351,577 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $8,085,882 | 333,576 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $7,593,485 | 299,664 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,083,399 | 304,689 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||